首页> 外国专利> Nortropanos substituted urea Derivatives, medicaments containing these Compounds, their use in the treatment of diseases mediated by the inhibition of the Enzyme 11beta hydroxysteroid dehydrogenase and Process for its preparation.

Nortropanos substituted urea Derivatives, medicaments containing these Compounds, their use in the treatment of diseases mediated by the inhibition of the Enzyme 11beta hydroxysteroid dehydrogenase and Process for its preparation.

机译:Nortropanos取代的尿素衍生物,包含这些化合物的药物,其在治疗中抑制酶11β羟类固醇脱氢酶介导的疾病的用途及其制备方法。

摘要

In particular, these compounds are inhibitors of 11b hydroxydehydrogenase (HSD) 1 and are therefore suitable for the treatment and prevention of diseases that may be affected by this enzyme inhibition, such as new and old metabolic diseases, especially type 2 diabetes, obesity and degreasing. It also provides a process to get it. ILO Convention No. 1: compounds with formula (1) in which R1 represents arilo or heterosexual, while arilo is defined as phenyl or northwest Africa, heterosexual as pyrethrum, furan, tienilo, pirid Nile, indolillo, benzofurania, benzotiflofennilo, quinurinilo,Isopentylenediol, i.e. pyridol, pyridylene, furan, velvet, pyridylene, in each case, one or two CH groups are replaced by N or indilo, benzofurania, benzotinil, quinolino or isoquinol Nile, in each case, one to three ch groups are replaced by n. Heteromorphic group, one or two groups, n = ch, optionally replaced by - nh-co - and / or - n (tar C1-4) - Co,Although the above alternative heteromorphic and polycyclic arilo groups are partially saturated, they retain an aromatic or heteroaromatic substructure (1) linked to the carbide group in the formulation,In a partially saturated ring, one or two optional ch groups are replaced, regardless of O, s, NH, n (C1-4 tar),1. Carbonate or sulfur, wherein the above groups of arilo, heterosexual, arilo and partially saturated heterosexual can be replaced by one or more substitutes, preferably one to four R2 substitutes, all heterosexual groups are combined with nortrophan structure (1) through carbon atom; Independent of each other,represent hydrogen, C1-6 alkyl, C3-6 alkenyl, C3-6 alkynyl, C3-6 cycloalkyl, (het) aryl, C1-4 alkylcarbonyl, C1-4 alkyloxycarbonyl, C1-4 alkylsulfonyl, (het) arylcarbonyl, (het ) arylsulfonyl, where each alkyl, alkenyl and alkynyl group is optionally also mono or polysubstituted with fluorine, and is optionally monosubstituted with hydroxy, C1-4 alkoxy, C1-4 alkylsulfanyl, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl, amino, alkylamino C1-4, di- (C1-4 alkyl) amino, C1-4 alkylcarbonylamino, cyano, carboxy, C1-4 alkoxycarbonyl, aminocarbonyl, C1-4 alkylaminocarbonyl, di- (C1-4 alkyl) aminocarbonyl or (het) aryl; R2, independently of each other,represent halogen, nitro, cyano, hydroxy, C3-6 cycloalkyl, C3-6 cycloalkyloxy, tetrahydrofuran-3-yloxy, tetrahydropyran-3-yoxy, tetrahydropyran-4-yloxy, tetrahydrofuranyl-C1-3 alkyloxy, tetrahydropyranyl-C1-3 alkyloxy , (het) aryl, (het) aryloxy, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkyloxy, C1-6 alkylamino, where in each group a CH2 group is optionally replaced by carbonyl or sulfonyl , and where each group is optionally mono or polyfluorinated, and where each group is optionally further substituted with hydroxy, chloro, C1-3 alkyloxy, amino, C1-3 alkylamino, di- (C1-3 alkyl) -amino, pyrrolidin-1 -yl, 2-oxo-pyrrolidin-1-yl, piperidin-1-yl,2-oxo-piperidin-1-ilo morfolin-4-ilo 3-oxo-morfolin-4-ilo piperazin-1-ilo 2-oxo-piperazin-1-ilo 3-oxo-piperazin-1-ilo 4- (alquil ciano aminocarbonilo alquilaminocarbonilo C1-3 di- (alquil C1-3) -aminocarbonilo pirrolidin-1-ilcarbonilo piperidin-1-ilcarbonilo morfolin-4-ilcarbonilo piperazin-1-ilcarbonilo 4- (alquil C1-3) -piperazin-1 1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-erazin-1-ilo, (HET) arilcarbonibamino, C1-4 hydrocarbon formaldehyde, Aminomethylamine, c1-4-aminotoluene amide, hydrocarbonyl c1-4-aminotoluene amide (HET) arilaminocarbonilamino, di - (c1-3 tar) ammonium carbamate, pirrolidin-1-ilcboniamino, piperidin-1-ilcboniamino, morfolin-4-ilcboniamino, piperazin-1-ilcboniamine, 4 - (c1-3) - pirerazin-1-ilcboniamine, fonilamino-c13,- 1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1) carbon - (HET) arilcarboni lamino, 3) - 1-3) - 1 - (1 (HET) arilsulfonilamino,N- (C1-3 alkyl) - (het) aryl-C1-3 alkylsulfonylamino, carboxy, C1-3 alkyloxycarbonyl, aminocarbonyl, C1-3 alkylaminocarbonyl, di (C1-3 alkyl) -aminocarbonyl, azetidin-1-ylcarbonyl, pyrrolidine -1-ylcarbonyl, piperidin-1-yl-carbonyl, morpho-4-ylcarbonyl, piperazin-1-ylcarbonyl, 4- (C1-3 alkyl) -piperazin-1-yl-carbonyl, (het) arylaminocarbonyl, N- ( C1-3 alkyl) - (het) aryl aminocarbonyl, (het) aryl C1-3 alkylaminocarbonyl, N- (C1-3 alkyl) - (het) aryl C1-3 alkylaminocarbonyl, (het) arylcarbonyl, C1- alkylsulfanyl 3, C1-3 alkylsulfinyl, (het) arylsulfonyl, tritluoromethylsulfanyl, trifluoromethylsulfinyl, aminosulfonyl, C1-3 alkylaminosulfonyl, di- (C1-3 alkyl) -aminosulfonyl,Pirrolidin-1-il-sulfonil, piperidin-1-ilsulfoni, morfolin-4-ilsulfoni, piperazin-1-ilsulfoni, 4 - (c1-3-tar) - piperazin-1-ilsulfoni, all of which can be replaced by one or two independent fluorinated groups, C1-3, alcoxi c1-3, alcoxi c1-3-c1-3-hydrocarbyl c1-3 and hydroxy; V is cy5y6, O NRN; W is absent or cy7y8 o (cy7y8) - (cy9y10);X absent or c118y12 o (c118y12) - (cy139y14);V and W can also be combined into a C3-6 cyclododecyl chemical group, which consists of two carbon atoms adjacent to the aza cycle, one or two CH2 groups can be replaced, whether or not replaced by O, s, NRN, carbonate or sulfuryl, and optionally partially unsaturated and, optionally monkey - or Polychlorinated biphenyls, preferably monomorphic, are modified to be tetrasexual and replaced by selected substitutes, regardless of R3; V and W can also be combined into one (HET) group, using figs with two carbon atoms associated with the aza cycle; R3 represents halogen, C1-4 tar, cyanogen, carboxi, C1-4 tar,aminocarbonyl, C1-3 alkylaminocarbonyl, di- (C1-3 alkyl) -aminocarbonyl, hydroxy, C1-4 alkoxy, amino, C1-3 alkylamino, di- (C1-3 alkyl) -amino, C1-4 alkylcarbonylamino, N- C1-3 alkyl-C1-4 alkylcarbonylamino and (het) aryl, wherein each above-mentioned alkyl group is optionally mono or poly substituted with fluorine, and optionally monosubstituted with hydroxy, C1-4 alkoxy, C1-4 alkylsulfanyl, C1 alkylsulfinyl -4, C1-4 alkylsulfonyl, amino, C1-3 alkylamino, di- (C1-3 alkyl) amino, C1-4 alkylcarbonylamino, cyano, carboxy, C1-4 alkoxycarbonyl, aminocarbonyl, C1-4 alkylaminocarbonyl, di- (C1-4 alkyl) -aminocarbonyl or (het) aryl; Y1 to Y14,which may be identical and / or different, independently of each other, represent hydrogen, halogen, nitro, cyano, hydroxy, C3-6 cycloalkyl, C3-6 cycloalkyloxy, tetrahydrofuran-3-yloxy, tetrahydropyran-3-yloxy, tetrahydropyran-4- yloxy, tetrahydrofuranyl-C1-3 alkyloxy, tetrahydropyranyl-C1-3 alkyloxy, (het) aryl, (het) aryloxy, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkylamino, C1-6 alkylamino , where in each group, a CH2 group is optionally replaced by carbonyl or sulfonyl, and where each group is optionally mono or polyfluorinated, and where each group is optionally further substituted with hydroxy, chloro, C1-3 alkyloxy, amino, C1- alkyl 3-amino,di- (C1-3 alkyl) -amino, pyrrolidin-1-yl, 2-oxo-pyrrolidin-1-yl, piperidin-1-yl, 2-oxo-piperidin-1-yl, morpholin-4-yl, 3 -oxo-morpholin-4-yl, piperazin-1-yl, 2-oxo-piperazin-1-yl, 3-oxo-piperazin-1-yl, 4- (C1-3 alkyl) -piperazin-1-yl, 2-oxo-4- (C1-3 alkyl) -piperazin-1-yl, 3-oxo-4- (C1-3 alkyl) -piperazin-1-yl, carboxy, C1-3 alkyloxycarbonyl, cyano, aminocarbonyl , C1-3 alkylaminocarbonyl, di- (C1-3 alkyl) -aminocarbonyl, pyrrolidin-1-ylcarbonyl, piperidin-1-ylcarbonyl, morpholin-4-ylcarbonyl, piperazin-1-ylcarbonyl, 4- (C1-3 alkyl) - piperazin-1-ylcarbonyl, C1-3 alkylcarbonyl, (het) arylcarbonylamino, C1-3 alkylsulfanyl, C1-3 alkylsulfinyl, C1-3 alkyl sulfonyl,cicloalquilo C3-6 (het) arilo o (het) ariloxi amino di- (alquil C1-3) amino pirrolidin-1-ilo 2-oxo-pirrolidin-1-ilo piperidin-1-ilo 2-oxo-piperidin-1-
机译:特别是,这些化合物是11b羟基脱氢酶(HSD)1的抑制剂,因此适用于治疗和预防可能受该酶抑制作用影响的疾病,例如新旧代谢疾病,尤其是2型糖尿病,肥胖和脱脂。它还提供了获取它的过程。国际劳工组织公约第1号:具有化学式(1)的化合物,其中R1代表芳基或异性,而芳基被定义为苯基或西北非洲,异性为除虫菊,呋喃,蒂尼洛,尼罗河上的尼罗河,吲哚洛洛,苯并呋喃,苯并噻吩氟芬尼洛,奎奴啉基,异戊二醇,即吡啶醇,吡啶撑基,呋喃,天鹅绒,吡啶撑,在每种情况下,一个或两个CH基团被N或吲哚基,苯并呋喃,苯并噻吩基,喹啉基或异喹啉尼罗河取代,在每个案例中,一到三个ch基团被n取代。异型基团,一个或两个基团,n = ch,可选地由-nh-co-和/或-n(tar C1-4)-Co取代,尽管上述替代的多态和多环芳基部分饱和,但它们保留一个与配方中的碳化物基团相连的芳族或杂芳族亚结构(1),在部分饱和的环中,一个或两个可选的ch基团被取代,而不考虑O,s,NH,n(C1-4焦油),1。碳酸盐或硫,其中上述的芳基,异性基,芳基和部分饱和的异性基团可以被一个或多个取代基,优选1-4个R 2取代基所取代,所有的异性基团通过碳原子与正丁烯结构(1)结合;彼此独立地表示氢,C 1-6烷基,C 3-6烯基,C 3-6炔基,C 3-6环烷基,(杂)芳基,C 1-4烷基羰基,C 1-4烷氧基羰基,C 1-4烷基磺酰基( )芳基羰基,(het)芳基磺酰基,其中每个烷基,烯基和炔基也任选被氟单或多取代,并且任选被羟基,C1-4烷氧基,C1-4烷基硫烷基,C1-4烷基亚磺酰基,C1-4单取代烷基磺酰基,氨基,烷基氨基C1-4,二-(C1-4烷基)氨基,C1-4烷基羰基氨基,氰基,羧基,C1-4烷氧羰基,氨基羰基,C1-4烷基氨基羰基,二-(C1-4烷基)氨基羰基或(het)芳基; R 2彼此独立地表示卤素,硝基,氰基,羟基,C 3-6环烷基,C 3-6环烷氧基,四氢呋喃-3-基氧基,四氢吡喃-3-基氧基,四氢吡喃-4-基氧基,四氢呋喃基-C1-3烷氧基,四氢吡喃基-C1-3烷氧基,(杂)芳基,(杂)芳氧基,C1-6烷基,C2-6烯基,C2-6炔基,C1-6烷氧基,C1-6烷基氨基,其中每个基团中的CH2基团任选地被羰基或磺酰基取代,并且其中每个基团任选地被单或多氟取代,并且其中每个基团任选地进一步被羟基,氯,C 1-3烷氧基,氨基,C 1-3烷基氨基,二-(C 1-3烷基)取代)-氨基,吡咯烷-1-基,2-氧代吡咯烷-1-基,哌啶-1-基,2-氧代哌啶-1-基morfolin-4-ilo 3-氧代-morfolin-4-ilo哌嗪-1-ilo 2-氧代哌嗪-1-ilo 3-氧代哌嗪-1-ilo 4-(芳族钢琴氨基碳素alquilaminocarbonilo C1-3 di-(芳族C1-3)-氨基碳素吡咯烷基-1-ilcarbonilo哌啶-1 -ilcarbonilo morfolin-4-ilcarbonilo哌嗪-1-ilcarbonilo 4-(a lquil C1-3)-piperazin-1 1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-erazin -1-ilo,(HET)芳烃基氨基,C1-4烃甲醛,氨基甲胺,c1-4-氨基甲苯酰胺,烃基c1-4-氨基甲苯酰胺(HET)芳基氨基烃基氨基,二-(c1-3焦油)氨基甲酸铵,吡咯烷菌素- 1-ilbboniamino,piperidin-1-ilcboniamino,morfolin-4-ilcboniamino,piperazin-1-ilbbonamine,4-(c1-3)-pirerazin-1-ilbbonamine,fonilamino-c13,-1-1-1-1-1 -1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1)碳-(HET)阿立卡西lamino,3)- 1-3)-1-(1(HET)芳磺酰基氨基,N-(C1-3烷基)-(het)芳基-C1-3烷基磺酰基氨基,羧基,C1-3烷氧基羰基,氨基羰基,C1-3烷基氨基羰基,二(C1 -3烷基)-氨基羰基,氮杂环丁烷-1-基羰基,吡咯烷-1-基羰基,哌啶-1-基羰基,吗啉-4-基羰基,哌嗪-1-基羰基,4-(C1-3烷基)-哌嗪- 1-基-羰基,(杂)芳基氨基羰基,N-(C 1-3烷基)-(杂)芳基氨基羰基,(杂)芳基C1-3烷基氨基羰基,N-(C 1-3烷基)-(杂)芳基C1-3烷基氨基羰基,(杂)芳基羰基,C1-烷基硫烷基3,C1-3烷基亚磺酰基,(杂)芳基磺酰基,三氟甲基硫烷基,三氟甲基亚磺酰基,氨基磺酰基,C1-3烷基氨基磺酰基,二-(C1 -3烷基)-氨基磺酰基,吡咯烷-1-il-磺腈,哌啶-1-异磺酮,吗啉-4-异磺酮,哌嗪-1-异砜,4-(c1-3-tar)-哌嗪-1-异磺酮,全部其中一个可以被一个或两个独立的氟代基团取代,C1-3,醇C1-3,醇C1-3-C1-3-烃基C1-3和羟基; V为cy5y6,O NRN; W不存在或cy7y8 o(cy7y8)-(cy9y10); X不存在或c118y12 o(c118y12)-(cy139y14); V和W也可以合并为C3-6环十二烷基化学基团,该基团由两个相邻的碳原子组成在氮杂循环中,可以取代一个或两个CH2基团,无论是否被O,s,NRN,碳酸盐或硫磺基取代,以及任选地部分不饱和的,以及任选地猴-或多氯联苯,优选为单晶的,被修饰成四性的,并被选定的取代基取代,而与R 3无关;使用具有两个与氮杂循环相关的碳原子的无花果,V和W也可以合并为一个(HET)基团。 R 3代表卤素,C 1-4焦油,氰,羧基,C 1-4焦油,氨基羰基,C 1-3烷基氨基羰基,二(C 1-3烷基)-氨基羰基,羟基,C 1-4烷氧基,氨基,C 1-3烷基氨基,二-(C1-3烷基)-氨基,C1-4烷基羰基氨基,N-C1-3烷基-C1-4烷基羰基氨基和(杂)芳基,其中每个上述烷基任选被氟单或多取代,和任选地被羟基,C 1-4烷氧基,C 1-4烷基硫烷基,C 1-4烷基亚磺酰基-4,C 1-4烷基磺酰基,氨基,C 1-3烷基氨基,二-(C 1-3烷基)氨基,C 1-4烷基羰基氨基,氰基,羧基单取代C1-4烷氧羰基,氨基羰基,C1-4烷基氨基羰基,二-(C1-4烷基)-氨基羰基或(杂)芳基;彼此相同和/或不同的Y 1至Y 14分别代表氢,卤素,硝基,氰基,羟基,C 3-6环烷基,C 3-6环烷氧基,四氢呋喃-3-基氧基,四氢吡喃-3-基氧基,四氢吡喃-4-基氧基,四氢呋喃基-C1-3烷氧基,四氢吡喃基-C1-3烷氧基,(杂)芳基,(杂)芳氧基,C1-6烷基,C2-6烯基,C2-6炔基,C1-6烷基氨基C1-6烷基氨基,其中每个基团中的CH2基团可选地被羰基或磺酰基取代,其中每个基团可选地被单或多氟取代,并且每个基团还可选地被羟基,氯,C1-3烷氧基取代,氨基,C1-烷基3-氨基,二-(C1-3烷基)-氨基,吡咯烷-1-基,2-氧代吡咯烷-1-基,哌啶-1-基,2-氧代哌啶-1-基yl,吗啉-4-基,3-氧代吗啉-4-基,哌嗪-1-基,2-氧哌嗪-1-基,3-氧哌嗪-1-基,4-(C1-3烷基)-哌嗪-1-基,2-氧代-4-(C1-3烷基)-哌嗪-1-基,3-氧代-4-(C1-3烷基)-哌嗪-1-基,羧基,C1 -3烷氧羰基,氰基,氨基羰基,C1-3烷基氨基羰基,二-(C1-3烷基)-氨基羰基,吡咯烷基-1-基羰基,哌啶-1-基羰基,吗啉-4-基羰基,哌嗪-1-基羰基,4-(C1 -3烷基)-哌嗪-1-基羰基,C1-3烷基羰基,(杂)芳基羰基氨基,C1-3烷基硫烷基,C1-3烷基亚磺酰基,C1-3烷基磺酰基,环氯喹啉C3-6(杂)芳基(杂)芳基氨基二((C1-3邻氨基)氨基吡咯烷酮-1-ilo 2-氧代吡咯烷酮-1-ilo哌啶-1-ilo 2-氧代哌啶-1-

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号